ConductScience.org, home

Paper999783

Complement activation in vivo in cancer patients receiving C. parvum immunotherapy.

Biran H and 6 others. Br J Cancer, 1976. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. Complement activation in vivo in cancer patients receiving C. parvum immunotherapy. Papers, record 999783. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/999783

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Complement activation in vivo in cancer patients receiving C. parvum immunotherapy.
PubMed
Journal
Br J Cancer
PubMed
Year
1976
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
0.25
iCite
Revised in PubMed
2019-05-15
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Biran HH
2Moake JLJ L
3Reed RCR C
4Gutterman JUJ U
5Hersh EME M
6Freireich EJE J
7Mavligit GMG M

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Complement System ProteinsMajor topic
ImmunotherapyMajor topic
NeoplasmsMajor topic
Propionibacterium acnesMajor topic
Complement C3
Complement C4
Humans

Source PubMed

Download CSV of topics

References24

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11078754Hemolytic anemia associated with multiple autoantibodies and low serum complement.Am J Med1975https://conductscience.org/library/papers/1078754PubMed
21079320Surface receptors in the immune response.N Engl J Med1975https://conductscience.org/library/papers/1079320PubMed
31080521Daily intravenous infusions of Corynebacterium parvum in twenty patients with disseminated cancer: a preliminary report of clinical and biologic findings.J Natl Cancer Inst1975https://conductscience.org/library/papers/1080521PubMed
41093298Immunologic approaches to the management of primary and secondary tumors involving the skin and soft tissues: review of a ten-year program.Transplant Proc1975https://conductscience.org/library/papers/1093298PubMed
51156505Further analysis of the anti-tumour effect in vitro of peritoneal exudate cells from mice treated with Corynebacterium parvum.Br J Cancer1975https://conductscience.org/library/papers/1156505PubMed
61204238Activation of the classical and alternate pathways of complement by Corynebacterium parvum.Clin Exp Immunol1975https://conductscience.org/library/papers/1204238PubMed
7167939Changes in lactate dehydrogenase enzyme pattern in Chinese hamster cells infected and transformed with Simian virus 40.Cancer Res1975https://conductscience.org/library/papers/167939PubMed
84138438Properties of an antigenic polysaccharide from Corynebacterium parvum.J Bacteriol1974https://conductscience.org/library/papers/4138438PubMed
94176223Interactions of the complement system with endotoxic lipopolysaccharide: consumption of each of the six terminal complement components.J Exp Med1968https://conductscience.org/library/papers/4176223PubMed
104262000The complement system of man (second of four parts).N Engl J Med1972https://conductscience.org/library/papers/4262000PubMed
114419513The effect of a single and repeated administration of Corynebacterium parvum on bone marrow macrophage colony production in syngeneic tumor-bearing mice.Cancer Res1974https://conductscience.org/library/papers/4419513PubMed
124459276Immunoprophylaxis and immunotherapy for a murine fibrosarcoma with C. granulosum and C. parvum.Int J Cancer1974https://conductscience.org/library/papers/4459276PubMed
134501536Enhanced resistance of mice to infection with bacteria following pre-treatment with Corynebacterium parvum.Nat New Biol1972https://conductscience.org/library/papers/4501536PubMed
144544736Nodular lymphoma--evidence for origin from follicular B lymphocytes.N Engl J Med1974https://conductscience.org/library/papers/4544736PubMed
154549691Tumour growth, phagocytic activity and antibody response in Corynebacterium parvum-treated mice.Clin Exp Immunol1974https://conductscience.org/library/papers/4549691PubMed
164610080Induction of guinea pig B-cell lymphokine synthesis by mitogenic and nonmitogenic signals to Fc, Ig, and C3 receptors.J Exp Med1974https://conductscience.org/library/papers/4610080PubMed
1747148Activation of the properdin pathway of complement in patients with gram-negative bacteremia.N Engl J Med1975https://conductscience.org/library/papers/47148PubMed
184722915BCG stimulation of immune responsiveness in patients with malignant melanoma. Preliminary report.Cancer1973https://conductscience.org/library/papers/4722915PubMed
194810906Lasting rejection of mammary adenocarcinoma cell tumors in DBA-2 mice with intratumor injection of killed Corynebacterium parvum.Cancer Res1974https://conductscience.org/library/papers/4810906PubMed
204841814In vitro inhibition of tumour cell growth and DNA synthesis by peritoneal and lung macrophages from mice injected with Corynebacterium parvum.Int J Cancer1974https://conductscience.org/library/papers/4841814PubMed

See all 24 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
602233Personal experience with Corynebacterium parvum in human cancers.World J Surg1977https://conductscience.org/library/papers/602233PubMed
145872Intense tumour-cell destruction by syngeneic mice: role of macrophages, complement activation and tumour-cell factors.Br J Cancer1977https://conductscience.org/library/papers/145872PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
C3718PubTator's text mininghttps://conductscience.org/library/genes/718NCBI Gene
CFP5199PubTator's text mininghttps://conductscience.org/library/genes/5199NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/999783

GET https://conductscience.org/api/papers/v1/999783/references?page=2